Investors & News

About Vivoryon

Vivoryon Therapeutics is a precision intervention company focused on discovering and developing first-in-class therapies for patients suffering from for age-related diseases.

We have built a pipeline of product candidates across various stages of development, currently focused on Alzheimer’s disease and cancer immune checkpoint inhibition.

Dieser Wertpapierprospekt ist ab dem 8. Oktober 2020 nicht mehr gültig. Eine Pflicht zur Erstellung eines Prospektnachtrags im Falle wichtiger neuer Umstände, wesentlicher Unrichtigkeiten oder wesentlicher Ungenauigkeiten besteht seit dem 30. Oktober 2019 nicht mehr.

This Prospectus is no longer valid as of 8 October 2020. An obligation to prepare a prospectus supplement in the event of significant new factors, material mistakes or material inaccuracies does not apply after 30 October 2019.


November 2019

11 – 13: BIO Europe, Hamburg, Germany